Ruilope LM - Search Results

1

Valsartan improves fibrinolytic balance in atherosclerotic rabbits.

Oubiña MP, de Las Heras N, Vázquez-Pérez S, Cediel E, Sanz-Rosa D, Ruilope LM, Cachofeiro V, Lahera V. Oubiña MP, et al. Among authors: ruilope lm. J Hypertens. 2002 Feb;20(2):303-10. doi: 10.1097/00004872-200202000-00021. J Hypertens. 2002. PMID: 11821716

2

Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.

Ruilope L. Ruilope L. J Hypertens Suppl. 1997 Dec;15(7):S15-20. J Hypertens Suppl. 1997. PMID: 9532516 Review.

3

Factors influencing the systolic blood pressure response to drug therapy.

Campo C, Segura J, Ruilope LM. Campo C, et al. Among authors: ruilope lm. J Clin Hypertens (Greenwich). 2002 Jan-Feb;4(1):35-40. doi: 10.1111/j.1524-6175.2002.00487.x. J Clin Hypertens (Greenwich). 2002. PMID: 11821635 Free PMC article. Review.

4

ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations?

Ruilope LM, Coca A, Volpe M, Waeber B. Ruilope LM, et al. Am J Hypertens. 2002 Apr;15(4 Pt 1):367-71. doi: 10.1016/s0895-7061(02)02258-6. Am J Hypertens. 2002. PMID: 11991225

5

N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients.

Barrios V, Calderón A, Navarro-Cid J, Lahera V, Ruilope LM. Barrios V, et al. Among authors: ruilope lm. Blood Press. 2002;11(4):235-9. doi: 10.1080/08037050213760. Blood Press. 2002. PMID: 12361192 Free article. Clinical Trial.

6

Hypertension magnitude and management in the elderly population of Spain.

Banegas JR, Rodríguez-Artalejo F, Ruilope LM, Graciani A, Luque M, de la Cruz-Troca JJ, García-Robles R, Tamargo J, Rey-Calero J. Banegas JR, et al. Among authors: ruilope lm. J Hypertens. 2002 Nov;20(11):2157-64. doi: 10.1097/00004872-200211000-00014. J Hypertens. 2002. PMID: 12409953

7

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

Ruilope LM, Usan L, Segura J, Bakris GL. Ruilope LM, et al. J Hypertens. 2004 Jan;22(1):217-22. doi: 10.1097/00004872-200401000-00032. J Hypertens. 2004. PMID: 15106814 Clinical Trial.

8

Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.

Calvo C, Hermida RC, Ayala DE, Ruilope LM. Calvo C, et al. Among authors: ruilope lm. J Hypertens. 2004 Apr;22(4):837-46. doi: 10.1097/00004872-200404000-00028. J Hypertens. 2004. PMID: 15126927 Clinical Trial.

9

Do we need to target 'prediabetic' hypertensive patients?

Segura J, Campo C, Ruilope LM, Rodicio JL. Segura J, et al. Among authors: ruilope lm. J Hypertens. 2005 Dec;23(12):2119-25. doi: 10.1097/01.hjh.0000191907.11606.cc. J Hypertens. 2005. PMID: 16269951 Review.

10

Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.

Ruilope LM, Després JP, Scheen A, Pi-Sunyer X, Mancia G, Zanchetti A, Van Gaal L. Ruilope LM, et al. J Hypertens. 2008 Feb;26(2):357-67. doi: 10.1097/HJH.0b013e3282f2d625. J Hypertens. 2008. PMID: 18192851 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

783 results

Search Page

Filters